C. Corbett

发表

Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation

M. Armstrong, B. Gunson, P. Muiesan, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Tobacco Smoking and Solid Organ Transplantation

J. Neuberger, M. Armstrong, C. Corbett, 2012, Transplantation.

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

S. Forbes, C. Yap, D. Stocken, 2017, The lancet. Gastroenterology & hepatology.

Granulocyte colony-stimulating factor and autologous CD 133-positive stem-cell therapy in liver cirrhosis ( REALISTIC ) : an open-label , randomised , controlled phase 2 trial

S. Forbes, C. Yap, D. Stocken, 2017 .

Alcohol and Substance Abuse in Solid-Organ Transplant Recipients

J. Neuberger, M. Armstrong, R. Parker, 2013, Transplantation.

CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.

James J. Campbell, C. Weston, D. Adams, 2018, American journal of physiology. Gastrointestinal and liver physiology.

Mental Health Disorders and Solid-Organ Transplant Recipients

J. Neuberger, M. Armstrong, R. Parker, 2013, Transplantation.

JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1

M. Buti, M. Biermer, O. Ackaert, 2019, Hepatology.

HTLV-1 in Solid-Organ Transplantation: Current Challenges and Future Management Strategies

J. Neuberger, M. Armstrong, I. Rowe, 2012, Transplantation.

CC Chemokine Receptor 2 Promotes 1 Recruitment of Myeloid Cells Associated with 2 Insulin Resistance in Non-Alcoholic Fatty Liver 3 Disease 4

James J. Campbell, C. Weston, D. Adams, 2018 .

Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study

A. Ghezzi, G. Aithal, Aditi Kumar, 2017, Journal of Gastroenterology.

Pharmacokinetics and Pharmacodynamics of the Non‐Nucleoside Reverse‐Transcriptase Inhibitor Etravirine in Treatment‐Experienced HIV‐1‐Infected Patients

E. Snoeck, J. Wade, M. Peeters, 2010, Clinical pharmacology and therapeutics.

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO)

M. Buti, J. Calleja, M. Diago, 2017, Alimentary pharmacology & therapeutics.

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Etravirine (ETR) in Treatment-Experienced HIV-1 Infected Patients: Pooled 48-Week Results of DUET-1 and DUET-2

M. Peeters, J. Vingerhoets, T. Kakuda, 2008 .

Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis

M. Armstrong, D. Houlihan, R. Parker, 2013, Alimentary pharmacology & therapeutics.

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol

S. Forbes, C. Yap, D. Stocken, 2015, BMJ Open.

A Study Protocol for a Randomised Controlled Trial

C. Yap, D. Stocken, I. Guha, 2022 .

Split liver transplant recipients do not have an increased frequency of acute kidney injury

M. Armstrong, B. Gunson, D. Mirza, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Novel markers of liver fibrosis

C. Corbett, 2015 .

Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.

J. Neuberger, A. Cheung, H. Janssen, 2014, Journal of hepatology.

Early occurrence of new‐onset diabetes after transplantation is related to type of liver graft and warm ischaemic injury

D. Mirza, S. Bramhall, J. Isaac, 2015, Liver international : official journal of the International Association for the Study of the Liver.

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection

F. Zoulim, A. Horban, P. Buggisch, 2018, Virology Journal.

Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice

J. Hodson, S. Hübscher, M. Armstrong, 2013, Postgraduate Medical Journal.

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study

M. Diago, P. Ferenci, J. George, 2017, BMC Infectious Diseases.

P7: Daclatasvir + sofosbuvir with or without ribavirin in patients with chronic HCV infection: interim analysis of a multicenter compassionate use program

M. Rizzetto, S. Ouwerkerk-Mahadevan, R. Flisiak, 2014 .

Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

Alexander E. Lopez, Aaron M. King, Andrew L Blumenfeld, 2021, Journal of hepatology.

Reticulocyte Count and Hemoglobin Concentration Predict Survival in Candidates for Liver Transplantation

J. Hodson, M. Armstrong, B. Gunson, 2014, Transplantation.

JNJ‐4178 (AL‐335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus‐Infected Patients Without Cirrhosis: OMEGA‐1

M. Buti, M. Biermer, O. Ackaert, 2019, Hepatology.

Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.

J. Neuberger, A. Cheung, H. Janssen, 2014, Journal of hepatology.